Elevated c-Myb levels due to overexpression or inappropriate activation by structural alterations of the protein sequence lead to a block in differentiation and contribute to the onset of certain human leukaemias, in particular AML, CML and T-ALL [49]. Here, MYB is linked to chronic myelogenous leukemia, BCR-ABL1 positive.